Voyager Technologies signs Geisinger as first major VISTA life sciences partner
VOYG•Voyager expands VISTA into life sciences with Geisinger
Voyager Technologies signed a memorandum of understanding with Geisinger, expanding its VISTA space-research park into life sciences and biopharma.
The parties will jointly pursue up to $1 million in external funding for microgravity-enabled clinical and biomedical research programs.
The deal reserves research resources, tenant access and payload development support via Starlab, accelerating pathways from space-based research to patient care.
